Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
AVANOS MEDICAL, INC. shows accelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +9% YoY in Q1 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 22d ago
AVNS's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on AVNS.
Free accounts see more of this; Premium sees all of it.
Reported figures for AVANOS MEDICAL, INC. — research only, not investment advice.
Updated
What happened recently for AVANOS MEDICAL, INC. (AVNS) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
AVNS's AI investment thesis
Upgrade to Premium for AVNS's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$24.99
Market cap
$1.17B
Profitable
Yes
Revenue $182.20M
Net income
$5.10M
FY Sep 11, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for AVANOS MEDICAL, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow AVANOS MEDICAL, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.